Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study.

Journal:

Journal of Clinical Oncology

Published:

2025-06-26

DOI:

10.1200/jco-24-02495

Affiliations:

35

Authors:

37

Go to article

Institutions	Authors	Share
Hengrui, China	3.000000	0.08
Fudan University Shanghai Cancer Center (FUSCC), China	2.000000	0.05
Shandong Cancer Hospital, China	1.000000	0.03
Hubei Cancer Hospital (HBCH), China	1.000000	0.03
Harbin Medical University Cancer Hospital, China	1.000000	0.03
The First Affiliated Hospital, USTC, China	1.000000	0.03
Beijing Obstetrics and Gynecology Hospital, Capital Medical University, China	1.000000	0.03
Cancer Hospital of Yunnan Province, China	1.000000	0.03
The First Affiliated Hospital of Xi'an Jiaotong University, XJTU, China	1.000000	0.03
The First Affiliated Hospital of Bengbu Medical University, China	1.000000	0.03
Zhejiang Cancer Hospital (ZJCH), China	1.000000	0.03
Henan Cancer Hospital, ZZU, China	1.000000	0.03
Obstetrics and Gynecology Hospital, Fudan University, China	1.000000	0.03
Liaoning Cancer Hospital and Institute, China	1.000000	0.03
Xiangya Hospital, CSU, China	1.000000	0.03
Drum Tower Hospital, China	1.000000	0.03
Tumor Hospital of Guangxi Medical University, China	1.000000	0.03
Sun Yat-sen University Cancer Center (SYSUCC), SYSU, China	1.000000	0.03
Sichuan Cancer Hospital, China	1.000000	0.03
Shanxi Cancer Hospital, China	1.000000	0.03
Anhui Provincial Cancer Hospital, China	1.000000	0.03
The First Affiliated Hospital of Henan University of Science and Technology, China	1.000000	0.03
Weifang People's Hospital, China	1.000000	0.03
Tianjin Medical University Cancer Institute and Hospital, TMU, China	1.000000	0.03
Jiangxi Provincial Cancer Hospital, China	1.000000	0.03
Fujian Cancer Hospital, China	1.000000	0.03
Wuhan Union Hospital, HUST, China	1.000000	0.03
Sun Yat-sen Memorial Hospital, SYSU, China	1.000000	0.03
The First Affiliated Hospital of Chongqing Medical University, China	1.000000	0.03
Hospital and Cancer Center, CQU, China	1.000000	0.03
Guizhou Cancer Hospital, Guizhou Medical University, China	1.000000	0.03
The First Hospital of Jilin University, China	1.000000	0.03
Tianjin Central Hospital of Gynecology and Obstetrics, China	1.000000	0.03
Hunan Cancer Hospital, China	0.500000	0.01
Xiangya School of Medicine, CSU, China	0.500000	0.01

Interested in Oncology and Carcinogenesis?